| 1/2 | US=84-A / Biol/Mol Suzuki E, Albelda SM. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble type II transforming growth factor-B receptor inhibits tumorigenesis by augmenting host ntitumor immunity. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 697-706. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; IMUNIDADE ANTITUMORAL; MESOTELIOMA MALIGNO; SOLUVEL DO TIPO II DO RECEPTOR DE TGF-B |
| 2/2 | US=37 / Câncer Schirrmacher V. Tumor immunology. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 31-7. ISBN 978-1-5889-0323-0. CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; IMUNOLOGIA DOS TUMORES; ANTIGENOS TUMORAIS; IMUNIDADE ANTITUMORAL |